 |
MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corp (OTCBB: RMCP) has filed for patent protection in Australia, which finalizes all the countries identified to be the utmost important for its proprietary Rev Vac safety syringe. China, Japan, Mexico, Canada, and Europe international patent protection rights have already been filed. “As we get closer to the marketing of our proprietary Rev Vac safety syringe, it was clear to us to have our patents protected internationally. With the completion of the Australian filing we feel very comfortable that we have fully protected our syringe from patent infringement and now we look to protect our 4 US pending patents, internationally, for our proprietary Rev Color MRI and Rev 3D MRI technology,” states Ron Wheet, CEO, Revolutions Medical Corporation.
In June of 2007, Revolutions Medical Corporation filed 4 US patents for its proprietary technology for MRI, including color, 3D, and auto segmentation of images. Revolutions Medical Corporation recently received communication from the PCT patent office handling international filings for the Rev Med MRI technologies. The PCT are the basis for international patent protection for Europe and are proceeding according to plans. “The indications are that our technology claims in our pending 4 US patents are strong and Rev Med will be filing additional international patent protection in a number of other countries as well as Europe,” says Richard Theriault, president Strategic Product Development, consultant to Revolutions Medical Corporation.
About Revolutions Medical Corporation
Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.
Safe Harbor
Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.
Contacts
Revolutions Medical Corporation
Investor Relations, 843-408-6265
www.revolutionsmedical.com
ip
|
